RBC Capital Downgrades CG Oncology to Sector Perform, Raises Price Target to $97
Benzinga Newsdesk 11 hours ago
Analyst RatingsNewsDowngradesPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
RBC Capital analyst Leonid Timashev downgrades CG Oncology (NASDAQ:CGON) from Outperform to Sector Perform and raises the price target from $80 to $97.
RBC Capital analyst Leonid Timashev downgrades CG Oncology (NASDAQ:CGON) from Outperform to Sector Perform and raises the price target from $80 to $97.
